Evecxia Therapeutics

United States
Creve Coeur, Missouri, United States, 27709

Company profile

Evecxia Therapeutics company profile

Evecxia Therapeutics is a pharmaceutical company that develops drugs to help patients suffering from disabling neuropsychiatric conditions. It aims to develop and commercialize EVX-101 to treat patients suffering from disabling, common, and costly neuropsychiatric conditions for which current therapies are inadequate, in particular depression. The company was established in 2013 and is based in Raleigh, North Carolina.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2013-01-01

Headquarters

Postal code
27709
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$20.1M
Last funding
Series A / $5M / 2025-09-22
Last equity funding
Series A / $5M
Investors
2
Founders
2
Articles
14

Founders and investors

Founders

Jacob JacobsenMarc Caron

Investors

Daren CotterViva BioInnovator